Validations: AI/ML Model Validation in GxP Analytics

Verification vs Validation for AI/ML: What Each Proves

Verification vs Validation for AI/ML: What Each Proves Verification vs Validation for AI/ML: What Each Proves Artificial Intelligence and Machine Learning (AI/ML) technologies are increasingly being integrated into various pharmaceutical and clinical solutions. Nevertheless, understanding the difference between verification and validation in the context of AI/ML model validation is crucial for maintaining compliance with regulatory requirements in the US, UK,…

Continue Reading Verification vs Validation for AI/ML: What Each Proves

Test Protocols for Models: Unit, Integration, and System

Test Protocols for Models: Unit, Integration, and System In the ever-evolving landscape of pharmaceutical research and clinical operations, the advent of Artificial Intelligence (AI) and Machine Learning (ML) has introduced a paradigm shift in data analytics. Proper validation of AI/ML models that are employed under Good Automated Manufacturing Practice (GxP) guidelines is essential. This article serves as a step-by-step tutorial…

Continue Reading Test Protocols for Models: Unit, Integration, and System

Performance Metrics: ROC, PR, Regression, and Calibration

Performance Metrics: ROC, PR, Regression, and Calibration Performance Metrics: ROC, PR, Regression, and Calibration Introduction to Performance Metrics in AI/ML Model Validation The integration of artificial intelligence (AI) and machine learning (ML) within the pharmaceutical industry presents unique challenges, especially in terms of compliance with Good Automated Manufacturing Practice (GxP) standards. These technologies have the potential to revolutionize drug development…

Continue Reading Performance Metrics: ROC, PR, Regression, and Calibration

Model Use Restrictions: Where Not to Use AI

Model Use Restrictions: Where Not to Use AI Model Use Restrictions: Where Not to Use AI The integration of Artificial Intelligence (AI) and Machine Learning (ML) models into pharmaceutical environments has accelerated innovation and enhanced efficiencies. However, their application is not without concerns. This tutorial guide will elucidate the intricacies of AI/ML model validation, particularly focusing on the intended use,…

Continue Reading Model Use Restrictions: Where Not to Use AI

Edge Cases & Rare Events: Handling Strategies

Edge Cases & Rare Events: Handling Strategies Edge Cases & Rare Events: Handling Strategies Introduction to AI/ML Model Validation in GxP Analytics Artificial Intelligence (AI) and Machine Learning (ML) have revolutionized various sectors, particularly in pharmaceutical and clinical operations. The application of these technologies necessitates rigorous validation processes to ensure compliance with Good Automated Manufacturing Practice (GxP) regulations. AI/ML model…

Continue Reading Edge Cases & Rare Events: Handling Strategies

Ground Truth Drift: Monitoring and Refresh

Ground Truth Drift: Monitoring and Refresh in AI/ML Model Validation In the evolving landscape of pharmaceutical development, the integration of artificial intelligence (AI) and machine learning (ML) into Good Practice (GxP) analytics has become imperative. As organizations adopt these advanced technologies, ensuring compliance with regulatory expectations such as 21 CFR Part 11, Annex 11, and GAMP 5 is crucial. This…

Continue Reading Ground Truth Drift: Monitoring and Refresh

Transfer Learning in GxP: Evidence Expectations

Transfer Learning in GxP: Evidence Expectations Transfer Learning in GxP: Evidence Expectations Introduction to Transfer Learning in GxP In the era of digital transformation, the pharmaceutical industry is increasingly harnessing the power of Artificial Intelligence (AI) and Machine Learning (ML) to enhance operational efficiencies and improve patient outcomes. However, with the introduction of these advanced technologies comes the need for…

Continue Reading Transfer Learning in GxP: Evidence Expectations

Domain Shift Across Sites: Parity and Exceptions

Domain Shift Across Sites: Parity and Exceptions The integration of artificial intelligence (AI) and machine learning (ML) within Good Practice (GxP) analytics is reshaping pharmaceutical validation processes. This guide seeks to provide a comprehensive step-by-step tutorial on the validation of AI/ML models, with a particular focus on domain shift across sites, ensuring compliance with regulatory expectations under the US FDA,…

Continue Reading Domain Shift Across Sites: Parity and Exceptions

Intended Use Storyboards for Inspections

Intended Use Storyboards for Inspections Intended Use Storyboards for Inspections Introduction to AI/ML Model Validation The utilization of Artificial Intelligence (AI) and Machine Learning (ML) in GxP (Good Practice) analytics has become a cornerstone of modern pharmaceutical development. As the complexity of these technologies increases, regulatory bodies such as the FDA, EMA, and MHRA have provided guidance to ensure compliance…

Continue Reading Intended Use Storyboards for Inspections

Case Library: Data Readiness Wins and Fails

Case Library: Data Readiness Wins and Fails In the realm of pharmaceutical development, the integration of AI and machine learning (ML) into Good Automated Manufacturing Practice (GxP) analytics has become increasingly vital. The validation of these models, specifically in terms of data readiness, intended use, and bias, is crucial for regulatory compliance. The purpose of this guide is to provide…

Continue Reading Case Library: Data Readiness Wins and Fails